EMvision Medical DevicesASX:EMV +3.97%33 EBIT per Share is A$-0.10 as of Dec. 2025. GuruFocus rates ASX:EMV with a GF Score™ of 33/100. The stock has 3 warning signs investors should review. Among 690 Medical Devices & Instruments companies, EMvision Medical Devices ranks worse than 70.29% on this metric.
EMvision Medical Devices's EBIT per Share for the
six
months ended in Dec. 2025 was A$-0.04.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.10.
During the past 3 years, the average EBIT per Share Growth Rate was -5.50% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -11.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for EMvision Medical Devices's EBIT per Share or its related term are showing as below:
ASX:EMV'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -19.3 Med: -9.9 Max: -5
Current: -5.5
During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of EMvision Medical Devices was -5.00% per year. The lowest was -19.30% per year. And the median was -9.90% per year.
ASX:EMV's 3-Year EBIT Growth Rate is ranked worse than 70.29% of 690
companies
in the Medical Devices & Instruments industry
Industry Median: 9.5
vs ASX:EMV: -5.50
EMvision Medical Devices (ASX:EMV) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
EMvision Medical Devices EBIT per Share Related Terms
EMvision Medical Devices EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.10
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EMvision Medical Devices (ASX:EMV) has a EBIT per Share of A$-0.10 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on EMvision Medical Devices and its competitors. According to the industry distribution chart, EMvision Medical Devices ranks #485 out of 690 companies in the Medical Devices & Instruments industry, placing it in the top 70.3%.
Is EMvision Medical Devices' EBIT per Share too high?
EMvision Medical Devices' current EBIT per Share is A$-0.10. Based on the distribution chart, EMvision Medical Devices ranks #485 out of 690 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, EMvision Medical Devices has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does EMvision Medical Devices' EBIT per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, EMvision Medical Devices ranks #485 out of 690 companies for EBIT per Share. This places EMvision Medical Devices in the lower half of its industry. The industry median EBIT per Share is 9.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.50, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on EMvision Medical Devices and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EMvision Medical Devices's current EBIT per Share is A$-0.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EMvision Medical Devices stock overvalued right now?
EMvision Medical Devices (ASX:EMV) has a current EBIT per Share of A$-0.10. The current EBIT per Share is A$-0.10. EMvision Medical Devices' overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For EMvision Medical Devices (ASX:EMV), the current EBIT per Share is A$-0.10 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
EMvision Medical Devices Ltd is an Australian medical device company. The company is focused on the research and development, and commercialisation of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. Its focus is portable, cost-effective, and non-invasive brain scanners, including a bedside device (emu) and an ultra-lightweight pre-hospital device (First Responder). Its first indication targets acute stroke care, with a second planned indication in traumatic brain injury.
33GF Score
Get the complete analysis for ASX:EMV
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EMV has been successfully added to your 
